4//SEC Filing
SPECTRUM PHARMACEUTICALS INC 4
Accession 0001209191-16-130133
CIK 0000831547operating
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 7:44 PM ET
Size
10.7 KB
Accession
0001209191-16-130133
Insider Transaction Report
Form 4
LENAZ LUIGI MD
Chief Scientific Officer
Transactions
- Award
Common Stock, $0.001 par value
2016-06-28+10,000→ 62,202 total - Award
Stock Option (Right to Buy)
2016-06-28$6.33/sh+20,000$126,600→ 20,000 totalExercise: $6.33Exp: 2026-06-28→ Common Stock (20,000 underlying) - Tax Payment
Common Stock, $0.001 par value
2016-06-27$6.47/sh−625$4,044→ 54,702 total - Tax Payment
Common Stock, $0.001 par value
2016-06-28$6.33/sh−2,500$15,825→ 52,202 total
Footnotes (3)
- [F1]Represents restricted shares withheld by Spectrum to satisfy Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.
- [F2]100% of the restricted shares shall vest on the earlier of (1) June 28, 2017 or (2) the date of the company's 2017 Annual Meeting of Shareholders.
- [F3]25% of the option shares vested on June 28, 2016. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000831547
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 7:44 PM ET
- Size
- 10.7 KB